Athira Pharma

About:

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

Website: https://athira.com/

Twitter/X: athirapharma

Top Investors: Franklin Templeton, Perceptive Advisors, Sofinnova Investments, RTW Investments, Viking Global Investors

Description:

Athira Pharma is a clinical-stage drug development company striving to improve human health by advancing bold and innovative therapies with the potential to restore the lives of people impacted by brain disorders. Athira is derived from the word Athir, the energy that reaches everyone. It captures its mission to develop therapies that can reach and positively impact everyone.

Total Funding Amount:

$234M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)athira.com

Founders:

Joseph Harding, Leen Kawas, Lewis Rumpler

Number of Employees:

51-100

Last Funding Date:

2021-01-20

IPO Status:

Public

Industries:

© 2025 bioDAO.ai